First New York Securities’s Pfizer PFE Stock Holding History

First New York Securities’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,459	Closed	-$3.46K	–	581
2014 Q2	$3.46K	Buy	+1,459	New	+$41.6K	﹤0.01%	148
2013 Q4	–	Sell	-89,063	Closed	-$2.43M	–	358
2013 Q3	$2.43M	Buy	+89,063	New	+$2.42M	0.97%	23

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

First New York Securities's PFE Position: Q2 2016 in Review

First New York Securities sold out of Pfizer (PFE) in Q2 2016, closing a stake of 21,185 shares — an estimated $596K sold.

First New York Securities first reported a position in PFE in Q2 2013 and held it in 5 quarters. The position peaked at $596K in Q1 2016. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

First New York Securities reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
First New York Securities sold 21,185 Pfizer shares in Q2 2016, an estimated $596K.
First New York Securities first reported a position in Pfizer in Q2 2013 and held it in 5 quarters.
First New York Securities's Pfizer position peaked at $596K in Q1 2016.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on First New York Securities's 13F filing for Q2 2016, filed 27 Jul 2016.